Skip to main content

Main navigation

  • About
    • Members
    • Staff
    • Annual Report
    • Rutgers-NPC 2023 Health Policy & Communications Fellowship
    • Health Policy Fellowship (Archive)
    • Contact Us
  • Topics
    • Health Spending
      • Understanding Health Spending
      • Low-Value Care
      • Health Spend Management
      • 340B Drug Pricing Program
    • Value Assessment
      • Value Assessment Frameworks
      • Value Assessment Methods
      • Elements of Value
    • Alternative Payment Models
      • Value-Based Contracts
      • Regulatory Barriers & Challenges
      • Paying for Cures
      • Accountable Care Organizations
      • Bundled Payments
      • Health Care Quality Measures
      • Clinical Pathways
    • Patient Centered Formulary & Benefit Design
      • High-Deductible Health Plans
      • Value-Based Insurance Design
      • Utilization Management & Step Therapy
      • Formulary Development
      • Patient Cost Sharing
      • Individual Treatment Effects & Personalized Access
    • Evidence for Decision Making
      • Real-World Data
      • Real-World Evidence
      • Good Practices for Evidence
    • Biopharma Innovation
      • Impact on Outcomes & Spending
  • Resources
    • Research
    • Letters & Comments
    • E.V.I.dently Today Blog
    • Events
    • CER Daily Newsfeed®
    • E.V.I.dently® Newsletter
    • Videos and Graphics
    • Press Room
      • NPC in the News
    • Stakeholder Resources
      • For Employers
      • For Patient Organizations
      • Going Below The Surface
  • Get Involved
    • Become a Member
    • Submit a Research Proposal
    • Start a Career
National Pharmaceutical Council

Offscreen menu

User account menu

  • Member Resources

Sharon Phares, PhD, MPH

  • Read more about Sharon Phares, PhD, MPH

NPC in Health Affairs: Payment Innovation Not Keeping Up

  • Read more about NPC in Health Affairs: Payment Innovation Not Keeping Up

NPC Reiterates Comments on Medicare Program; Medicare Coverage of Innovative Technology, Definition of “Reasonable and Necessary”

  • Read more about NPC Reiterates Comments on Medicare Program; Medicare Coverage of Innovative Technology, Definition of “Reasonable and Necessary”

Designing Successful Bundled Payment Initiatives

  • Read more about Designing Successful Bundled Payment Initiatives

Are Payers Ready to Address the Financial Challenges Associated with Gene Therapy?

  • Read more about Are Payers Ready to Address the Financial Challenges Associated with Gene Therapy?

Are Value-based Arrangements the Answer We’ve Been Waiting for?

  • Read more about Are Value-based Arrangements the Answer We’ve Been Waiting for?

NPC in STAT: Paying for Curative Therapies: Our Challenges in Addressing Medicine’s Solutions

  • Read more about NPC in STAT: Paying for Curative Therapies: Our Challenges in Addressing Medicine’s Solutions

Symposium: Able to Cure, Able to Pay — Closing the Widening Gap

  • Read more about Symposium: Able to Cure, Able to Pay — Closing the Widening Gap

NPC in Specialty Pharmacy Times: Creative Financing for Innovative, Curative Therapies

  • Read more about NPC in Specialty Pharmacy Times: Creative Financing for Innovative, Curative Therapies

Key Takeaways From an ISPOR Panel on Creative Financing Proposals

  • Read more about Key Takeaways From an ISPOR Panel on Creative Financing Proposals

Pagination

  • Page 1
  • Next page
Subscribe to Alternative Payment Models

Let's stay in touch.

Subscribe to Our Newsletter
© 2021 NPC. All rights reserved.

Footer Menu

  • Accessibility
  • Privacy Policy
  • Terms of Use
  • Contact Us

Footer Social Links Menu

  • Twitter
  • Linkedin
  • Youtube